New Biomolecular Capabilities for the Melbourne Magnetic Resonance Facility

墨尔本磁共振设施的新生物分子功能

• 批准号: LE210100130
• 负责人: Prof Paul Gooley
• 金额: $ 66.68万
• 依托单位: The University of Melbourne
• 依托单位国家: 澳大利亚
• 项目类别: Linkage Infrastructure, Equipment and Facilities
• 财政年份: 2021
• 资助国家: 澳大利亚
• 起止时间: 2021-05-07 至 2022-12-31
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/LE210100130
• 关键词: New; Biomolecular; Capabilities; Melbourne; Magnetic

The project aims to integrate new instrumentation, which does not currently exist in Australia, into the Melbourne Biomolecular Nuclear Magnetic Resonance (NMR) facility. This will introduce new capabilities to the Australian NMR community to characterise important biological molecular interactions at low concentrations. This project expects to support existing areas of research strength with new approaches across interdisciplinary research programs in biochemistry, structural biology, medicinal and natural product chemistry. Expected outcomes from a range of research with a variety of partners will underpin new, potentially commercially valuable, applications across the chemical, pharmaceutical, agricultural or manufacturing industries.

该项目旨在将澳大利亚目前没有的新仪器纳入墨尔本生物分子核磁共振设施。这将为澳大利亚核磁共振界带来新的能力，以在低浓度下研究重要的生物分子相互作用。该项目预计将支持现有的研究实力与跨学科的研究计划在生物化学，结构生物学，医药和天然产物化学的新方法领域。与各种合作伙伴进行的一系列研究的预期成果将为化学、制药、农业或制造业的新的、具有潜在商业价值的应用奠定基础。